Abcam Plc (ABC)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Abcam Plc (ABC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013857
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondary antibodies, immunoassay kits and reagents, cell and tissue imaging tools, cellular and biochemical assays, proteins and peptides, proteomics tools, agonists, activators, antagonists and inhibitors, lysates, and multiplex miRNA assay. Abcam’s products are used by academic researchers to identify proteins for life sciences and veterinary sciences. The company distributes its products in the Americas, Europe the Middle East, Africa and Asia-Pacific. Abcam is headquartered in Cambridge, Cambridgeshire, the UK.

Abcam Plc (ABC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Abcam Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Abcam Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Abcam Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Abcam Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Abcam Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Abcam Plc, Medical Equipment, Deal Details 11
Venture Financing 11
Firefly BioWorks Raises USD0.8 Million in Venture Financing 11
Firefly BioWorks Secures US$2 Million In Series A Venture Financing 12
Partnerships 13
Abcam Enters Into Licensing Agreement With Columbia University For Fluorescent False Neurotransmitters 13
TTP LabTech and Abcam Enter into Partnership 14
Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 15
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 16
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 17
Dako Denmark Enters Into Co-Development Agreement With Epitomics 18
Equity Offering 19
Epitomics Withdraws IPO Of Common Stock 19
Acquisition 20
Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 20
Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For US$155 Million 21
Abcam Acquires MitoSciences 22
Abcam Plc – Key Competitors 23
Abcam Plc – Key Employees 24
Abcam Plc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Strategy And Business Planning 27
Oct 24, 2016: Abcam commits to the lease of a new facility on the Cambridge Biomedical Campus 27
Financial Announcements 29
Sep 11, 2017: Abcam: Double-digit earnings growth enabling investment for sustained future growth 29
Sep 12, 2016: ABCAM: Strong revenue performance enabling investment for future growth 30
Mar 07, 2016: Abcam delivers sustained double digit revenue growth whilst investing in the future 34
Corporate Communications 35
Nov 15, 2017: ABCAM: Result of AGM and Directorate Change 35
Oct 11, 2017: Abcam: Directorate Change – Chairman 36
Jun 20, 2016: Abcam to appoint Gavin Wood, former Affymetrix executive, as Chief Financial Officer 37
Mar 07, 2016: Abcam: Directorate Change 38
Other Significant Developments 39
Jul 27, 2017: Abcam: Pre-Close Period Update 39
May 18, 2017: Abcam Makes Final Performance-Based AxioMx Milestone Payment 40
Mar 06, 2017: Abcam: Interim Results delivering double digit sales growth 41
Jul 25, 2016: Abcam: Pre-Close Period Update 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Abcam Plc, Medical Equipment, Key Facts, 2017 2
Abcam Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Abcam Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Abcam Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Abcam Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Abcam Plc, Deals By Market, 2011 to YTD 2017 9
Abcam Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Firefly BioWorks Raises USD0.8 Million in Venture Financing 11
Firefly BioWorks Secures US$2 Million In Series A Venture Financing 12
Abcam Enters Into Licensing Agreement With Columbia University For Fluorescent False Neurotransmitters 13
TTP LabTech and Abcam Enter into Partnership 14
Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 15
Abcam Enters into Co-Marketing Agreement with Cell Marque for IVD IHC RabMAb Antibodies 16
Firefly BioWorks Enters Into Distribution Agreement With EMD Millipore 17
Dako Denmark Enters Into Co-Development Agreement With Epitomics 18
Epitomics Withdraws IPO Of Common Stock 19
Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 20
Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For US$155 Million 21
Abcam Acquires MitoSciences 22
Abcam Plc, Key Competitors 23
Abcam Plc, Key Employees 24
Abcam Plc, Subsidiaries 25

★海外企業調査レポート[Abcam Plc (ABC)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • eFront S.A.:企業の戦略的SWOT分析
    eFront S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Avista Corporation (AVA)-エネルギー分野:企業M&A・提携分析
    Summary Avista Corporation (Avista) is an electric and natural gas utility. The company produces, transmits, and distributes electricity; and supplies natural gas on retail and wholesale basis. It sources electricity from its facilities and contracted hydroelectric, thermal and wind generation facil …
  • Synedgen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Synedgen Inc (Synedgen) is a biotechnology company that discovers and develops polysaccharide-based drugs, which enhance and mimic the innate immune system. The company’s pipeline products include SYGN305, SYGN399, SYGN303, SYGN313 and SYGN309. Synedgen develops products for the treatment of …
  • Telekom Slovenije, d.d. (TLSG):企業の財務・戦略的SWOT分析
    Telekom Slovenije, d.d. (TLSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • SM Energy Co (SM):企業の財務・戦略的SWOT分析
    SM Energy Co (SM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Plantronics, Inc. (PLT):企業の財務・戦略的SWOT分析
    Plantronics, Inc. (PLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Power Machines:企業の戦略的SWOT分析
    Power Machines - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Infant Bacterial Therapeutics AB (IBT B):製薬・医療:M&Aディール及び事業提携情報
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • Maruha Nichiro Corporation:戦略・SWOT・企業財務分析
    Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report Summary Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Edgars Stores Limited:企業の戦略・SWOT・財務情報
    Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report Summary Edgars Stores Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cyclopharm Ltd (CYC):医療機器:M&Aディール及び事業提携情報
    Summary Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in the nuclear medicine business. The company’s products include Technegas, a lung imaging device used to diagnose the presence of blood clots in the lungs; and posi …
  • Hindustan Unilever Ltd (HINDUNILVR):企業の財務・戦略的SWOT分析
    Hindustan Unilever Ltd (HINDUNILVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Hershey Co:戦略・SWOT・企業財務分析
    The Hershey Co - Strategy, SWOT and Corporate Finance Report Summary The Hershey Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Trane Inc:企業の戦略的SWOT分析
    Trane Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報
    Summary Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens nat …
  • Carlsberg A/S:企業の戦略・SWOT・財務情報
    Carlsberg A/S - Strategy, SWOT and Corporate Finance Report Summary Carlsberg A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sumitomo Electric Industries Ltd (5802):企業の財務・戦略的SWOT分析
    Sumitomo Electric Industries Ltd (5802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Moravske naftove doly AS:企業の戦略的SWOT分析
    Moravske naftove doly AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Victorian WorkCover Authority:企業の戦略的SWOT分析
    Victorian WorkCover Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Nuclear Power Corporation of India Ltd-エネルギー分野:企業M&A・提携分析
    Summary Nuclear Power Corporation of India Ltd (NPCIL) designs, constructs, commissions and operates nuclear power reactors. It is controlled and governed by the Department of Atomic Energy (DAE), Government of India. The company generates power from nuclear with pressurized heavy water reactor, lig …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆